BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 18190907)

  • 1. Flurazepam inhibits the P-glycoprotein transport function: an insight to revert multidrug-resistance phenotype.
    Lima SA; Tavares J; Gameiro P; de Castro B; Cordeiro-da-Silva A
    Eur J Pharmacol; 2008 Feb; 581(1-2):30-6. PubMed ID: 18190907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of P-glycoprotein activity and reversal of cancer multidrug resistance by Momordica charantia extract.
    Limtrakul P; Khantamat O; Pintha K
    Cancer Chemother Pharmacol; 2004 Dec; 54(6):525-30. PubMed ID: 15248030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cepharanthin, a multidrug resistant modifier, is a substrate for P-glycoprotein.
    Hirai M; Tanaka K; Shimizu T; Tanigawara Y; Yasuhara M; Hori R; Kakehi Y; Yoshida O; Ueda K; Komano T
    J Pharmacol Exp Ther; 1995 Oct; 275(1):73-8. PubMed ID: 7562598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gomisin A alters substrate interaction and reverses P-glycoprotein-mediated multidrug resistance in HepG2-DR cells.
    Wan CK; Zhu GY; Shen XL; Chattopadhyay A; Dey S; Fong WF
    Biochem Pharmacol; 2006 Sep; 72(7):824-37. PubMed ID: 16889754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitor.
    Fox E; Bates SE
    Expert Rev Anticancer Ther; 2007 Apr; 7(4):447-59. PubMed ID: 17428165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX; Yang XH
    Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol interaction with the daunorubicin binding site of P-glycoprotein.
    Wang E; Casciano CN; Clement RP; Johnson WW
    Biochem Biophys Res Commun; 2000 Oct; 276(3):909-16. PubMed ID: 11027568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of P-glycoprotein and multidrug resistance protein 1 by dietary phytochemicals.
    Nabekura T; Yamaki T; Ueno K; Kitagawa S
    Cancer Chemother Pharmacol; 2008 Oct; 62(5):867-73. PubMed ID: 18204840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of P-glycoprotein tryptophan residues to benzodiazepines and ATP interaction.
    Lima SA; Cordeiro-da-Silva A; de Castro B; Gameiro P
    Biophys Chem; 2007 Jan; 125(1):143-50. PubMed ID: 16919386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence-based assessment of LRP activity: a comparative study.
    Durdux M; Grunwald D; Gautier T; Ronot X; Boutonnat J
    Anticancer Res; 2004; 24(2B):725-32. PubMed ID: 15161018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
    Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
    Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
    Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human pharmaceuticals modulate P-gp1 (ABCB1) transport activity in the fish cell line PLHC-1.
    Caminada D; Zaja R; Smital T; Fent K
    Aquat Toxicol; 2008 Nov; 90(3):214-22. PubMed ID: 18950875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chemopreventive citrus phytochemicals on human P-glycoprotein and multidrug resistance protein 1.
    Nabekura T; Yamaki T; Kitagawa S
    Eur J Pharmacol; 2008 Dec; 600(1-3):45-9. PubMed ID: 18955043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of P-glycoprotein-mediated resistance by kaempferol derivatives isolated from Zingiber zerumbet.
    Chung SY; Jang DS; Han AR; Jang JO; Kwon Y; Seo EK; Lee HJ
    Phytother Res; 2007 Jun; 21(6):565-9. PubMed ID: 17335117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of P-glycoprotein-mediated multidrug resistance by acceleration of passive drug permeation across the plasma membrane.
    Regev R; Katzir H; Yeheskely-Hayon D; Eytan GD
    FEBS J; 2007 Dec; 274(23):6204-14. PubMed ID: 17986257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of the P-glycoprotein multidrug efflux pump with cholesterol: effects on ATPase activity, drug binding and transport.
    Eckford PD; Sharom FJ
    Biochemistry; 2008 Dec; 47(51):13686-98. PubMed ID: 19049391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro flow cytometry method to quantitatively assess inhibitors of P-glycoprotein.
    Wang EJ; Casciano CN; Clement RP; Johnson WW
    Drug Metab Dispos; 2000 May; 28(5):522-8. PubMed ID: 10772630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of the multidrug resistance P-glycoprotein in acetaminophen-induced toxicity in hepatoma-derived HepG2 and Hep3B cells.
    Manov I; Bashenko Y; Hirsh M; Iancu TC
    Basic Clin Pharmacol Toxicol; 2006 Sep; 99(3):213-24. PubMed ID: 16930294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine diminishes multidrug resistance in K562/ADM cells and improves complete remission in patients with acute myeloid leukemia.
    Li GY; Liu JZ; Zhang B; Wang LX; Wang CB; Chen SG
    Biomed Pharmacother; 2009 Sep; 63(8):566-70. PubMed ID: 19095404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.